Archives

  • Volume 2, Issue 3, Fall 2024

    • Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men
    • The Role of Bisphosphonate Drug Holidays in the Management of Osteoporosis
    • Treatment of Obesity in Individuals with Type 1 Diabetes
    • Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus
    • Monogenic and Syndromic Obesity: Therapeutic Implications

  • Volume 2, Issue 2, Summer 2024

    • Aging In The Face of Diabetes: Severe Hypoglycemia in Older Adults
    • Obstructive Sleep Apnea and Type 2 Diabetes
    • A Practical Approach to the Incidental Adrenal Mass
    • Finerenone in Diabetic Kidney Disease

  • Volume 2, Issue 1, Spring 2024

    • Risk Stratification to Improve Care and Outcomes in Diabetic Kidney Disease
    • Role of Continuous Glucose Monitoring in Non-Insulin-Requiring Type 2 Diabetes
    • From the Bottom Up: Foot Care in Diabetes and the Role of the Endocrinologist
    • Diabetes Management at Time of Childbirth
    • Diabetes and Osteoporosis

  • Volume 1, Issue 3, October 2023

    • Lipoprotein (a) in Cardiovascular Risk Assessment and Management in Diabetes Mellitus
    • Approach to the Management of Thyroid Eye Disease
    • The Role of Plant-Based Diets in the Management of Type 2 Diabetes
    • Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use
    • Case Report: A First Nation Man’s Journey with Severe Insulin Resistance Syndrome

  • Volume 1, Issue 2, June 2023

    • Endocrinopathies Associated with Immune Checkpoint Inhibitors
    • Future Role of Non-Insulin Antihyperglycemic Agents in the Management of Type 1 Diabetes Mellitus
    • Management of Pediatric Type 2 Diabetes: A Practical Overview of Current Guidelines and Emerging Therapies
    • Resistance Exercise in the Context of Type 1 Diabetes
    • Improving Access to Endocrinologists through Provider-to-Provider eConsultations

  • Volume 1, Issue 1, March 2023

    • How to Apply the Canadian Obesity Clinical Practice Guidelines to People with Type 2 Diabetes
    • Consideration of Cannabinoids in the Treatment of Diabetic Peripheral Neuropathic Pain
    • Type 2 Diabetes Remission: An Overview
    • The Use of Biosimilar Insulins in 2023
    • Addressing NAFLD as a Type 2 Diabetes Complication Using the Emerging Paradigms in Diagnostic and Management Techniques